| LINE ITEM (USD / %) | FY 2025
FILED 2025-09-30 | FY 2024
FILED 2024-09-30 | FY 2023
FILED 2023-09-30 |
|---|---|---|---|
| Revenue (Total Sales) | $40.00B | $35.93B | $32.65B |
| YoY Revenue Growth % | +11.3% | +10.0% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $23.99B | $23.59B | $21.00B |
| Operating Margin % | 60.0% | 65.7% | 64.3% |
| Net Income (GAAP) | $20.06B | $19.74B | $17.27B |
| EBITDA (Normalized) | $25.43B | $24.89B | $22.18B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $23.06B | $19.95B | $20.75B |
| Capital Expenditures (CapEx) | $1.80B | $1.62B | $1.47B |
| Free Cash Flow (FCF) | $21.26B | $18.33B | $19.29B |
| FCF Margin % | 53.1% | 51.0% | 59.1% |
| Return on Invested Capital (ROIC %) | 43.5% | 43.7% | 6.8% |
| Cash & Short-Term Equivalents | $14.76B | $12.37B | — |
| Total Debt (Short + Long Term) | $19.59B | $16.68B | $94.41B |
| Total Stockholders' Equity | $38.78B | $38.30B | $193.65B |